FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029641311> ?p ?o ?g. }

• W2029641311 endingPage "2712" @default.
• W2029641311 startingPage "2702" @default.
• W2029641311 abstract "Abstract Adult T‐cell leukemia (ATL) is a fatal malignancy of T lymphocytes caused by human T‐cell leukemia virus type 1 (HTLV‐1) infection and remains incurable. Carotenoids are a family of natural pigments and have several biological functions. Among carotenoids, fucoxanthin is known to have antitumorigenic activity, but the precise mechanism of action is not elucidated. We evaluated the anti‐ATL effects of fucoxanthin and its metabolite, fucoxanthinol. Both carotenoids inhibited cell viability of HTLV‐1‐infected T‐cell lines and ATL cells, and fucoxanthinol was approximately twice more potent than fucoxanthin. In contrast, other carotenoids, β‐carotene and astaxanthin, had mild inhibitory effects on HTLV‐1‐infected T‐cell lines. Importantly, uninfected cell lines and normal peripheral blood mononuclear cells were resistant to fucoxanthin and fucoxanthinol. Both carotenoids induced cell cycle arrest during G 1 phase by reducing the expression of cyclin D1, cyclin D2, CDK4 and CDK6, and inducing the expression of GADD45α, and induced apoptosis by reducing the expression of Bcl‐2, XIAP, cIAP2 and survivin. The induced apoptosis was associated with activation of caspase‐3, ‐8 and ‐9. Fucoxanthin and fucoxanthinol also suppressed IκBα phosphorylation and JunD expression, resulting in inactivation of nuclear factor‐κB and activator protein‐1. Mice with severe combined immunodeficiency harboring tumors induced by inoculation of HTLV‐1‐infected T cells responded to treatment with fucoxanthinol with suppression of tumor growth, showed extensive tissue distribution of fucoxanthinol, and the presence of therapeutically effective serum concentrations of fucoxanthinol. Our preclinical data suggest that fucoxanthin and fucoxanthinol could be potentially useful therapeutic agents for patients with ATL. © 2008 Wiley‐Liss, Inc." @default.
• W2029641311 created "2016-06-24" @default.
• W2029641311 creator A5013040583 @default.
• W2029641311 creator A5015575713 @default.
• W2029641311 creator A5018278375 @default.
• W2029641311 creator A5020839989 @default.
• W2029641311 creator A5029782156 @default.
• W2029641311 creator A5045875644 @default.
• W2029641311 creator A5051242188 @default.
• W2029641311 creator A5057000072 @default.
• W2029641311 creator A5060145424 @default.
• W2029641311 creator A5062789006 @default.
• W2029641311 creator A5080311577 @default.
• W2029641311 creator A5080431899 @default.
• W2029641311 creator A5085393435 @default.
• W2029641311 creator A5088695508 @default.
• W2029641311 date "2008-09-16" @default.
• W2029641311 modified "2023-10-18" @default.
• W2029641311 title "Antiadult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol" @default.
• W2029641311 cites W1519245680 @default.
• W2029641311 cites W1550247880 @default.
• W2029641311 cites W1905313439 @default.
• W2029641311 cites W1922883684 @default.
• W2029641311 cites W1968262266 @default.
• W2029641311 cites W1977911088 @default.
• W2029641311 cites W1980138415 @default.
• W2029641311 cites W1986362127 @default.
• W2029641311 cites W1994486114 @default.
• W2029641311 cites W2002762814 @default.
• W2029641311 cites W2016534065 @default.
• W2029641311 cites W2021413266 @default.
• W2029641311 cites W2028382049 @default.
• W2029641311 cites W2048022927 @default.
• W2029641311 cites W2058350611 @default.
• W2029641311 cites W2062205148 @default.
• W2029641311 cites W2066745496 @default.
• W2029641311 cites W2079929369 @default.
• W2029641311 cites W2083906562 @default.
• W2029641311 cites W2086143621 @default.
• W2029641311 cites W2102917371 @default.
• W2029641311 cites W2106708630 @default.
• W2029641311 cites W2111037825 @default.
• W2029641311 cites W2113391491 @default.
• W2029641311 cites W2113898023 @default.
• W2029641311 cites W2114877663 @default.
• W2029641311 cites W2122931119 @default.
• W2029641311 cites W2123679031 @default.
• W2029641311 cites W2130092087 @default.
• W2029641311 cites W2152105216 @default.
• W2029641311 cites W2161579926 @default.
• W2029641311 cites W2164471424 @default.
• W2029641311 cites W2170522323 @default.
• W2029641311 cites W2321606182 @default.
• W2029641311 cites W2322523258 @default.
• W2029641311 cites W3130825775 @default.
• W2029641311 doi "https://doi.org/10.1002/ijc.23860" @default.
• W2029641311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18798263" @default.
• W2029641311 hasPublicationYear "2008" @default.
• W2029641311 type Work @default.
• W2029641311 sameAs 2029641311 @default.
• W2029641311 citedByCount "116" @default.
• W2029641311 countsByYear W20296413112012 @default.
• W2029641311 countsByYear W20296413112013 @default.
• W2029641311 countsByYear W20296413112014 @default.
• W2029641311 countsByYear W20296413112015 @default.
• W2029641311 countsByYear W20296413112016 @default.
• W2029641311 countsByYear W20296413112017 @default.
• W2029641311 countsByYear W20296413112018 @default.
• W2029641311 countsByYear W20296413112019 @default.
• W2029641311 countsByYear W20296413112020 @default.
• W2029641311 countsByYear W20296413112021 @default.
• W2029641311 countsByYear W20296413112022 @default.
• W2029641311 countsByYear W20296413112023 @default.
• W2029641311 crossrefType "journal-article" @default.
• W2029641311 hasAuthorship W2029641311A5013040583 @default.
• W2029641311 hasAuthorship W2029641311A5015575713 @default.
• W2029641311 hasAuthorship W2029641311A5018278375 @default.
• W2029641311 hasAuthorship W2029641311A5020839989 @default.
• W2029641311 hasAuthorship W2029641311A5029782156 @default.
• W2029641311 hasAuthorship W2029641311A5045875644 @default.
• W2029641311 hasAuthorship W2029641311A5051242188 @default.
• W2029641311 hasAuthorship W2029641311A5057000072 @default.
• W2029641311 hasAuthorship W2029641311A5060145424 @default.
• W2029641311 hasAuthorship W2029641311A5062789006 @default.
• W2029641311 hasAuthorship W2029641311A5080311577 @default.
• W2029641311 hasAuthorship W2029641311A5080431899 @default.
• W2029641311 hasAuthorship W2029641311A5085393435 @default.
• W2029641311 hasAuthorship W2029641311A5088695508 @default.
• W2029641311 hasBestOaLocation W20296413111 @default.
• W2029641311 hasConcept C153911025 @default.
• W2029641311 hasConcept C190283241 @default.
• W2029641311 hasConcept C203014093 @default.
• W2029641311 hasConcept C2776913467 @default.
• W2029641311 hasConcept C2778461978 @default.
• W2029641311 hasConcept C2781231385 @default.
• W2029641311 hasConcept C28781525 @default.
• W2029641311 hasConcept C29537977 @default.
• W2029641311 hasConcept C55493867 @default.

• next